Journal
/
Medicine
/
Evaluating Murine BBB Disruption Induced by Hypoxic Human Placenta-Derived sEVs…
/
Isolering av normoxiska och hypoxiska humana placenta-härledda små extracellulära vesiklar för injektion i möss…
JoVE Journal
Medicine
Medicine
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Isolering av normoxiska och hypoxiska humana placenta-härledda små extracellulära vesiklar för injektion i möss
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/200731-v
•
01:35 min
•
January 26th, 2024
Isolering av normoxiska och hypoxiska humana placenta-härledda små extracellulära vesiklar för injektion i möss
Evaluating Murine BBB Disruption Induced by Hypoxic Human Placenta-Derived sEVs
January 26th, 2024
•
Hermes Sandoval*1, José León*1,2, Felipe Troncoso1, Valeria de la Hoz3, Aaron Cisterna3,4, Moisés Contreras1, Fidel O. Castro5, Belén Ibañez1, Jesenia Acurio1, Carlos Escudero1,6
1Vascular Physiology Laboratory, Department of Basic Sciences, Universidad del Bío-Bío, Chillan, 2Nursery School, Health Faculty, Universidad Santo Tomás, Los Angeles, 3Obstetrics and Gynecology Department, Herminda Martin Clinical Hospital, Chillan, 4Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepcion, 5Laboratory of Animal Biotechnology, Department of Animal Science, Faculty of Veterinary Sciences, Universidad de Concepción, Chillan, 6Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillan
* These authors contributed equally